# EDGAR Filing Document

**Accession Number:** 0001994911
**File Stem:** 0001994911-26-000005
**Filing Date:** 2026-5
**Character Count:** 2742
**Document Hash:** 6d1e26f7134a276c859e2e1eb0138aaf
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001994911-26-000005.hdr.sgml**: 20260507

**ACCESSION NUMBER**: 0001994911-26-000005

**CONFORMED SUBMISSION TYPE**: C-AR

**CONFIRMING COPY**: 

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260507

**DATE AS OF CHANGE**: 20260507

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rejuve Biotech Inc.
- **CENTRAL INDEX KEY:** 0001994911

**ORGANIZATION NAME:**
- **EIN:** 932218283
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-AR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-33659

**BUSINESS ADDRESS:**
- **STREET 1:** 982A N. BATAVIA STREET, SUITE 10B
- **CITY:** ORANGE
- **STATE:** CA
- **ZIP:** 92867
- **BUSINESS PHONE:** 5622098912

**MAIL ADDRESS:**
- **STREET 1:** 215 S ORANGE ST
- **STREET 2:** 215 SOUTH ORANGE STREET
- **CITY:** ORANGE
- **STATE:** CA
- **ZIP:** 92866

### Attached PDF Documents

**Attachment 1:** `formc-ar.pdf`

_No text found in this document._

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Rejuve Biotech Inc.

**Legal Status:** Corporation

**Jurisdiction of Incorporation/Organization:** CA

**Date of Organization:** 12-01-2022

**Physical Address:** 215 S Orange St, ORANGE, CA, 92866

**Issuer Website:** www.rejuve.bio

**Is there a Co-Issuer?:** No

### Offering Information

**Oversubscription Accepted:** No

### Annual Report Disclosure Requirements

**Current Number of Employees:** 6

**Total Assets (Most Recent Fiscal Year):** $136,091.80

**Total Assets (Prior Fiscal Year):** $257,811.00

**Cash & Cash Equivalents (Most Recent Fiscal Year):** $136,091.80

**Cash & Cash Equivalents (Prior Fiscal Year):** $257,811.00

**Accounts Receivable (Most Recent Fiscal Year):** $0.00

**Accounts Receivable (Prior Fiscal Year):** $0.00

**Short-Term Debt (Most Recent Fiscal Year):** $0.00

**Short-Term Debt (Prior Fiscal Year):** $0.00

**Long-Term Debt (Most Recent Fiscal Year):** $0.00

**Long-Term Debt (Prior Fiscal Year):** $0.00

**Revenues/Sales (Most Recent Fiscal Year):** $0.00

**Revenues/Sales (Prior Fiscal Year):** $0.00

**Cost of Goods Sold (Most Recent Fiscal Year):** $0.00

**Cost of Goods Sold (Prior Fiscal Year):** $0.00

**Taxes Paid (Most Recent Fiscal Year):** $0.00

**Taxes Paid (Prior Fiscal Year):** $0.00

**Net Income (Most Recent Fiscal Year):** $-57,800.40

**Net Income (Prior Fiscal Year):** $-13,513.00

### Signatures

**Issuer:** Rejuve Biotech Inc.

**Signature:** Kennedy Schaal

**Title:** CEO

---

**Signature:** Kennedy Schaal

**Title:** CEO

**Date:** 05-07-2026